These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20504451)

  • 21. Dopamine-rich grafts in the neostriatum and/or nucleus accumbens: effects on drug-induced behaviours and skilled paw-reaching.
    Abrous DN; Shaltot AR; Torres EM; Dunnett SB
    Neuroscience; 1993 Mar; 53(1):187-97. PubMed ID: 8469306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens.
    Lane RF; Blaha CD; Phillips AG
    Brain Res; 1986 Nov; 397(1):200-4. PubMed ID: 3801862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholecystokinin modulates mesolimbic dopaminergic influences on male rat copulatory behavior.
    Markowski VP; Hull EM
    Brain Res; 1995 Nov; 699(2):266-74. PubMed ID: 8616630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Locomotor hypokinesia in the reserpine-treated rat: drug effects from the corpus striatum and nucleus accumbens.
    Johnels B
    Pharmacol Biochem Behav; 1982 Aug; 17(2):283-9. PubMed ID: 7134238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
    Gygi SP; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological evidence for common mechanisms underlying the effects of neurotensin and neuroleptics on in vivo dopamine efflux in the rat nucleus accumbens.
    Blaha CD; Phillips AG
    Neuroscience; 1992 Aug; 49(4):867-77. PubMed ID: 1436486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased neuronal responsiveness to cholecystokinin and dopamine induced by lesioning mesolimbic dopaminergic neurons: an electrophysiological study in the rat.
    Debonnel G; de Montigny C
    Synapse; 1988; 2(5):537-45. PubMed ID: 2903570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitro.
    Marshall FH; Barnes S; Pinnock RD; Hughes J
    Br J Pharmacol; 1990 Apr; 99(4):845-8. PubMed ID: 2361176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of amphetamine and apomorphine on locomotor activity after kainic acid lesion of the nucleus accumbens septi in the rat.
    Kafetzopoulos E
    Psychopharmacology (Berl); 1986; 88(3):271-4. PubMed ID: 3083447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholecystokinin (CCK) increases GABA release in the rat anterior nucleus accumbens via CCK(B) receptors located on glutamatergic interneurons.
    Lanza M; Makovec F
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):33-8. PubMed ID: 10651144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mosaic distribution of phosphate-activated glutaminase-like immunoreactivity in the rat striatum.
    Kaneko T; Mizuno N
    Neuroscience; 1992 Jul; 49(2):329-45. PubMed ID: 1436471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic dopaminergic regulation of neuropeptide Y systems in discrete striatal and accumbens regions.
    Midgley LP; Wagstaff JD; Singh NA; Bush LG; Gibb JW; Hanson GR
    Eur J Pharmacol; 1994 Jan; 251(2-3):191-9. PubMed ID: 7908639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.
    Crawley JN; Hommer DW; Skirboll LR
    Brain Res; 1985 Jun; 335(2):337-41. PubMed ID: 4005562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of cholecystokinin receptors in the bovine brain: a quantitative autoradiographic study.
    Morency MA; Quirion R; Mishra RK
    Neuroscience; 1994 Sep; 62(1):307-16. PubMed ID: 7816208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of infusions of 6-hydroxydopamine into nucleus accumbens and anterolateral hypothalamus induced by 6-hydroxydopamine on the response to dopamine agonists, body weight, locomotor activity and measures of exploration in the rat.
    Winn P; Robbins TW
    Neuropharmacology; 1985 Jan; 24(1):25-31. PubMed ID: 3920545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single exposure to novelty differentially affects the accumbal dopaminergic system of apomorphine-susceptible and apomorphine-unsusceptible rats.
    van der Elst MC; Verheij MM; Roubos EW; Ellenbroek BA; Veening JG; Cools AR
    Life Sci; 2005 Feb; 76(12):1391-406. PubMed ID: 15670618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropeptide modulation of apomorphine-induced stereotyped behavior.
    Blumstein LK; Crawley JN; Davis LG; Baldino F
    Brain Res; 1987 Feb; 404(1-2):293-300. PubMed ID: 3567572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour.
    Costall B; Eniojukan JF; Naylor RJ
    Eur J Pharmacol; 1983 Dec; 96(3-4):201-10. PubMed ID: 6426976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of amphetamine and apomorphine on locomotor activity after 6-OHDA and electrolytic lesions of the nucleus accumbens septi.
    Kelly PH; Roberts DC
    Pharmacol Biochem Behav; 1983 Jul; 19(1):137-43. PubMed ID: 6413984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
    Weiss F; Ettenberg A; Koob GF
    Psychopharmacology (Berl); 1989; 99(3):409-15. PubMed ID: 2574480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.